- Country: USA
- Summary: Nextseq 2000 Service Contract Silver Support Plan (Ambis 2252502)
- UST Ref No: 116559543
- Deadline: 31 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: NOI-NIAID-25-2252502
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This is a Notice of Intent (NOI), not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate on an other than full and open competition basis with Illumina, Inc. 5200 Illumina Way, San Diego, CA 92122-4616, USA for the following: NEXTSEQ 2000 SERVICE CONTRACT SILVER SUPPORT PLAN, Cat. #20040667, S/N VH00286, quarterly billing.
This service contract renewal is needed to maintain our Illumina NextSeq 2000 sequencer. This service is completely comprehensive and includes full coverage for parts, labor and travel. Service also includes reagent replacement upon HW failures and remote technical support. Lastly, experiments in process have been conducted using services from this vendor and the lab must continue to use these products to avoid introducing error and outside variables that could result in the corruption of our experiments, thus leading to wasting of time and money. The vendor Illumina has extensive knowledge needed to repair there manufactured instruments, and they offer expertise in the intricacies of the instrumentation aforementioned in this requirement. Lastly, service must be provided by Illumina in order for our warranty to remain valid. Also, the continuity of reagents must stay the same to ensure that experimental results are not influenced by new variables and to avoid any long delays in testing products from other suppliers. Changing variables would prevent the correct interpretation of the experiments in progress.
The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for a 1-year service agreement for a NextSeq 2000 S/N# VH00286 Silver Support Plan.
The Contractor must provide the following services:
• Full coverage on OEM parts, labor, and travel
• OEM Reagent Replacement upon HW failures
• Preventative Maintenance (1)
• Remote Technical Support 18x5, 2 business day on-site response target
• Control SW ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNextseq 2000 Service Contract Silver Support Plan (Ambis 2252502) - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nextseq 2000 Service Contract Silver Support Plan (Ambis 2252502). This tender is published on USARFP under UST Ref No: 116559543 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
